BioNeMo vs Tempus — Comparison

BioNeMo

AI tools and models for healthcare innovation.

NVIDIA BioNeMo™ is the development platform for AI-driven biology and drug discovery. NVIDIA Nemotron™ is the foundation for digital health AI. NVIDIA Isaac™ is a robotics and simulation platform. MONAI is the open medical imaging AI framework. The NVIDIA Holoscan SDK is a runtime for physical AI and sensor processing. NVIDIA Parabricks® enables GPU-accelerated genomics. Curated, domain-specific, open source datasets to kickstart model development. Prebuilt CUDA-X™ libraries for math, deep learning, data processing, image, video, and more. Hardware-optimized libraries, training recipes, frameworks, and orchestration platforms. Open source AI models for biomedical research across omics, protein and molecule structures, medical imaging, 3D anatomy, surgical robotics, and digital twins for physics-informed simulation. Tools for optimizing performance, scaling inference workloads, and deploying across cloud, on-prem, and edge environments. The architecture centers on a dual-die design that packs 208 billion transistors into a unified package capable of 10 terabytes per second (TB/s) of GPU bandwidth. Its Transformer Engine supports FP4 precision, effectively doubling performance and capacity for generative AI workloads. Massive-scale deployments are handled through NVIDIA NVLink™ and NVSwitch™, delivering 1.8 TB/s per GPU and 130 TB/s of aggregate bandwidth for trillion-parameter models. A dedicated Decompression Engine offloads data-intensive analytics tasks from the CPU, while AI-driven remote access service (RAS) monitoring and a first-of-its-kind trusted execution environment (TEE)-capable GPU round out the platform with enterprise-grade reliability and confidential computing support. Inception is a free program that guides AI startups through the diverse NVIDIA platforms and ecosystems. From prototype to production, Inception meets each startup where they are, with member benefits to help them discover new AI opportunities, build with world-class technologies, and grow their business. NVIDIA Connect is a free program that helps software development companies and service providers shorten time to market through tailored development resources, technical training and guidance, and preferred pricing on NVIDIA technologies. The NVIDIA Deep Learning Institute (DLI) offers technical training from NVIDIA, so developers and researchers can gain in-demand skills, hands-on experience, and expert knowledge in AI, data science, accelerated computing, and more. Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services. Talk to an NVIDIA product specialist about your professional needs. Join the NVIDIA Developer Program to access free tech resources, support from forums, and expert training. Think of this as your personal guide to our "State of AI" reports. Whether you're curious about infrastructure o

Tempus

Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, startin

Christina Antoniou Senior Vice President, Head of Corporate Development Terron Bruner Chief Commercial Officer Ezra Cohen, MD Chief Medical Officer of Oncology Shane Colley Chief Technology Officer Robyn Eckerling Chief Privacy Officer Laura Elster Senior Vice President, Healthcare Innovation & Transformation Greg Fisbeck Chief Information Security Officer Ryan Fukushima Chief Operating Officer Stacey Kraft Chief People Officer Andy Moye, PhD SVP & GM, Data Products Halla Nimeiri, MD Chief Development Officer Phil Perez Senior Vice President, Commercial Life Sciences Erik Phelps EVP and Chief Administrative and Legal Officer Jim Rogers Chief Financial Officer Kate Sasser, PhD Chief Scientific Officer Tom Schoenherr CEO, Ambry Genetics Chris Scotto DiVetta Senior Vice President & General Manager of AI Applications Lauren Silvis Senior Vice President of External Affairs Patty Spiller Chief Marketing Officer Melisa Tucker Chief Data Officer Shane Woods, PhD Chief Strategy Officer Mike Yasiejko Executive Vice President and General Manager, Genomics “We are thrilled to have led an investment in Tempus... Given NEA's long and successful history investing in the intersection of technology and life science, we felt like the perfect strategic partner given Tempus' mission to help doctors personalize care by collecting and analyzing large volumes of data.” Peter Barris, Chairman & General Partner, New Enterprise Associates “The next major evolution in health care will be the embrace of data to dramatically improve patient outcomes, and I believe Tempus is the company that is best positioned to lead this transition. The team at Tempus is exceptional, and as committed to the mission as can be.” Eric Belcher, Chief Executive Officer, Numerator “I look forward to working with the Tempus team as they continue to apply technology and artificial intelligence to healthcare, deploying intelligent diagnostics that enhance research, empower physicians, and positively change the lives of patients.” Jennifer Doudna, PhD, Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute “Tempus has developed a distinct set of solutions that has real potential to revolutionize cancer care. I look forward to working with the leadership team in developing those offerings to provide even more value to the company, its partners, and ultimately patients.” David R. Epstein, Former Chief Executive Officer, Seagen “As a surgical oncologist, I have worked to reduce racial, ethnic and gender health care disparities throughout my career. Tempus is a leader in the field of data-driven medicine, and I am excited to work with their team to further enhance patient outcomes for individuals of all backgrounds and from all communities.” Wayne A. I. Frederick, MD, MBA, Charles R. Drew Professor of Surgery “I'm honored to be working with the Tempus team as they advance innovative tools for

BioNeMo

Tempus

BioNeMo

Tempus

BioNeMo

Tempus